Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) Return on Capital Employed (2021 - 2025)

Maxcyte (MXCT) has disclosed Return on Capital Employed for 5 consecutive years, with 0.27% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 24.0% to 0.27% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.27%, a 24.0% decrease, with the full-year FY2024 number at 0.22%, down 18.0% from a year prior.
  • Return on Capital Employed was 0.27% for Q3 2025 at Maxcyte, down from 0.25% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.02% in Q2 2024 to a low of 0.27% in Q3 2025.
  • A 5-year average of 0.12% and a median of 0.09% in 2022 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: rose 16bps in 2024, then fell -24bps in 2025.
  • Maxcyte's Return on Capital Employed stood at 0.07% in 2021, then plummeted by -47bps to 0.1% in 2022, then skyrocketed by 68bps to 0.03% in 2023, then crashed by -603bps to 0.22% in 2024, then dropped by -19bps to 0.27% in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Return on Capital Employed are 0.27% (Q3 2025), 0.25% (Q2 2025), and 0.23% (Q1 2025).